Pfizer found a way to boost its ailing stock — agree with Trump on drug pricing
1 week ago
6
ARTICLE AD BOX
Pfizer’s stock surged after CEO Albert Bourla announces an agreement with the Trump administration aimed at lowering drug prices in the U.S. and removing tariff uncertainty.